Viscient Bio Inc
PrivateLast Round
Convertible Debt
Sep 15, 2021
Total Funding Raised
$1M
Company Overview
Viscient Bio Inc operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Convertible Debt round in September 2021.
Viscient Bio Inc is a biotechnology company that develops novel therapies for liver diseases using proprietary 3D human tissue models.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, 3D Printing, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Viscient Bio Inc Comparables
Compare Viscient Bio Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VivoSim Labs, Inc. | 82% | |
| VoxCell BioInnovation | 81% | |
| InSphero | 80% |
For institutional investors. Book with your work email.
Viscient Bio Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Sep 15, 2021 | ||||
| Convertible Debt | May 30, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Viscient Bio Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SternAegis Ventures | Convertible Debt |
| Thynk Capital | Convertible Debt |
| Harmonix Fund | Convertible Debt |
| Methuselah Foundation | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 30, 2019
Harmonix Fund, methuselahfund, and Thynk Capital participated.
For institutional investors. Book with your work email.
Viscient Bio Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Viscient Bio Inc's valuation, stock price, and market status.
Is Viscient Bio Inc a public or private company?
Viscient Bio Inc is a private company.
What is the current stock price of Viscient Bio Inc?
Viscient Bio Inc is a private company, so its shares have no public market price. Caplight tracks Viscient Bio Inc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Viscient Bio Inc worth (valuation)?
Valuation information for Viscient Bio Inc is not publicly available.
Can I buy Viscient Bio Inc stock?
Viscient Bio Inc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Viscient Bio Inc's last funding round?
Viscient Bio Inc's most recent funding round was Convertible Debt on September 15, 2021.
Who are the main investors in Viscient Bio Inc?
Key investors in Viscient Bio Inc include SternAegis Ventures, Thynk Capital, Harmonix Fund, Methuselah Foundation.
Will Viscient Bio Inc IPO soon?
No public IPO plans have been announced for Viscient Bio Inc.
How can I track Viscient Bio Inc secondary market activity?
Caplight tracks bids, offers, and trades in Viscient Bio Inc's shares on secondary markets.